Sort
8,912 grants matching “sars cov 2”
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
$52,216Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2020 · AI
Evaluation of SARS-CoV 2'O Methyltransferase Mutants
$52,190Vineet D Menachery · Univ Of North Carolina Chapel Hill · F32 · FY2013 · AI
Developing Lectins as Inhibitors of Coronavirus Spike Proteins
$52,084Alex Joseph Guseman · University Of Pittsburgh At Pittsburgh · K99 · FY2023 · GM
Recombinant Engineering of SARS-CoV-2 Spike and N proteins
$51,958David Margulies · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Protective lung memory B cell functions and dynamics during respiratory infection
$51,752Neelou Etesami · Boston University Medical Campus · F30 · FY2022 · HL
Longitudinal mucosal immune response to SARS-CoV-2 starting prior to infection
$51,752Alexander Viloria Winnett · California Institute Of Technology · F30 · FY2022 · AI
Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections
$51,660Jeanne Sisk · Johns Hopkins University · F32 · FY2016 · AI
The Use of Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injury
$51,575Dimitrios Chrisovalantou Arhontoulis · Medical University Of South Carolina · F30 · FY2024 · HL
Role of SARS-CoV-2 Spike Protein and Accessory ORFs in the immune pathogenesis of COVID-19
$51,546John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The impact of immune escape on the epidemiology and evolutionary dynamics of the COVID-19 pandemic in Yucatan, Mexico
$51,452Guadalupe Ayora-Talavera · Autonomous University Of Yucatan · R03 · FY2023 · AI
The impact of immune escape on the epidemiology and evolutionary dynamics of the COVID-19 pandemic in Yucatan, Mexico
$51,452Guadalupe Ayora-Talavera · Autonomous University Of Yucatan · R03 · FY2024 · AI
SARS CoV2 Studies in the Microbial Pathogenesis Section/LPD
$51,366Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Molecular Mechanisms of SARS-CoV-2 Infection and Therapeutic Targets
$51,233Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Protective lung memory B cell functions and dynamics during respiratory infection
$51,036Neelou Etesami · Boston University Medical Campus · F30 · FY2021 · HL
SARS-CoV-2 pathogenesis and countermeasures
$50,981Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Induction and maintenance of SARS-CoV-2 mRNA vaccine-specific memory across tissues
$50,974Julia Meghan Davis-Porada · Columbia University Health Sciences · F30 · FY2024 · AI
Clinical Sample Collection COVID19 Patients to Align with NIAID National Study
$50,942Nitin S Baliga · Institute For Systems Biology · R01 · FY2021 · AI
Implementation and Evaluation of Two SARS-CoV-2 Assays for Companion Animal Testing to Expand Vet-LIRN COVID-19 Capacity
$50,938Stephen Douglas Cole · University Of Pennsylvania · U18 · FY2022 · FD
Development of a SARS-CoV-2 vaccine
$50,856Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Crossing scales to predict and prevent bat virus zoonoses in a Madagascar ecosystem
$50,856Cara Brook · University Of Chicago · DP2 · FY2025 · AI
Hepatocytes and skeletal myocytes shape immunity to mRNA-LNP encoded protein
$50,698Sophia Siu · Icahn School Of Medicine At Mount Sinai · F30 · FY2025 · AI
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism
$50,604Steffanie A Strathdee · University Of California, San Diego · R01 · FY2022 · DA
COVID-19 E protein biochemical studies
$50,010Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
I-Corps: Chemical-Free Advanced Oxidation Water Treatment System
$50,000Kevin M McPeak · Louisiana State University · · FY2021 · TIP
The Network for Investigation of Delirium: Unifying Scientists (NIDUS)'s 9th-13th Annual Delirium Boot Camps: A Foundation for Future Exploration
$50,000Jan Busby-Whitehead · Univ Of North Carolina Chapel Hill · R13 · FY2022 · AG